Colestipol Hydrochloride Patent Expiration
Colestipol Hydrochloride was first introduced by Pfizer Inc
Colestipol Hydrochloride Patents
Given below is the list of patents protecting Colestipol Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Colestid | US5490987 | Tableting of colestipol hydrochloride |
Feb 13, 2013
(Expired) | Pfizer |
Try Our Curated Drug Screens
Colestipol Hydrochloride Generics
Several generic applications have been filed for Colestipol Hydrochloride. The first generic version for Colestipol Hydrochloride was by Impax Laboratories Inc and was approved on May 2, 2006. And the latest generic version is by Ani Pharmaceuticals Inc and was approved on Mar 10, 2023.
Given below is the list of companies who have filed for Colestipol Hydrochloride generic.
1. ANI PHARMS
Ani Pharmaceuticals Inc has filed for 1 generic for Colestipol Hydrochloride. Given below are the details of the strengths of this generic introduced by Ani Pharms.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
1GM | tablet | Prescription | ORAL | AB | Mar 10, 2023 |
2. IMPAX LABS
Impax Laboratories Inc has filed for 3 different strengths of generic version for Colestipol Hydrochloride. Given below are the details of the strengths of this generic introduced by Impax Labs.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5GM/SCOOPFUL | granule | Prescription | ORAL | AB | May 2, 2006 |
5GM/PACKET | granule | Prescription | ORAL | AB | May 2, 2006 |
1GM
(reference standard) | tablet | Prescription | ORAL | AB | Oct 24, 2006 |
3. ZYDUS PHARMS
Zydus Pharmaceuticals Usa Inc has filed for 1 generic for Colestipol Hydrochloride. Given below are the details of the strengths of this generic introduced by Zydus Pharms.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
1GM | tablet | Prescription | ORAL | AB | Mar 10, 2022 |